Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events-Reference-Cited by-同舟云学术

Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events

Published:2019-01-15 Issue:3 Volume:62 Page:217-222
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Bongomin Felix¹²^ORCID,Maguire Niamh³,Moore Caroline B.³,Felton Timothy²⁴,Rautemaa‐Richardson Riina²³⁵

Affiliation:

1. National Aspergillosis CentreECMM Centre of Excellence in Clinical and Laboratory Mycology and Clinical StudiesWythenshawe HospitalManchester University NHS Foundation Trust Manchester UK

2. Division of Infection, Immunity and Respiratory MedicineFaculty of Biology, Medicine and HealthUniversity of Manchester Manchester UK

3. Mycology Reference Centre ManchesterECMM Centre of Excellence in Clinical and Laboratory Mycology and Clinical StudiesWythenshawe HospitalManchester University NHS Foundation Trust Manchester UK

4. Acute Intensive Care UnitWythenshawe HospitalManchester University NHS Foundation Trust Manchester UK

5. Department of Infectious DiseasesWythenshawe Hospital Manchester University NHS Foundation Trust Manchester UK

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.12885

Reference13 articles.

1. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis

2. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

3. Chronic Cavitary and Fibrosing Pulmonary and Pleural Aspergillosis: Case Series, Proposed Nomenclature Change, and Review

4. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

5. Assessment of posaconazole salvage therapy in chronic pulmonary aspergillosis using predefined response criteria

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isavuconazole Versus Voriconazole as the First-line Therapy for Solid Organ Transplant Recipients With Invasive Aspergillosis: Comparative Analysis of 2 Multicenter Cohort Studies;Transplantation;2024-05-21

2. Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges;Therapeutic Advances in Infectious Disease;2024-01

3. A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections;Mycoses;2023-06-10

4. New Systemic Antifungal: Isavuconazole;New Antimicrobials: For the Present and the Future;2023

5. Clinical research advances of isavuconazole in the treatment of invasive fungal diseases;Frontiers in Cellular and Infection Microbiology;2022-12-01